NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

TTRX | NASDAQ

$13.31 -$1.08 | -7.51%
SIGNAL:Signal available — unlock to view |2026-09-03 |F&G 82 |RSI 55.1

Company Overview:

Market Cap: $396.48M
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $2.57 - $26.50

1 Year TTRX Performance Metrics:

Total Return (with DRIP): 90.1% (90.14% CAGR)
Total Return (no DRIP): 90.1% (90.14% CAGR)
Share Price: 90.1% (90.14% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $19,014
Total Return $ (with DRIP): $9,014
TTRX Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
TTRX Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

TTRX Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

TTRX - Revenue
TTRX Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Earnings Per Share (EPS)
TTRX EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Net Income
🔓 See the full chart40% off right now · 7-day free trial
TTRX Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
TTRX EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
TTRX Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
TTRX Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
TTRX Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
TTRX Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
TTRX Shares Outstanding CAGR:1Y: 116.74%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
TTRX Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
TTRX Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Expenses
🔓 See the full chart40% off right now · 7-day free trial
TTRX Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
TTRX - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
TTRX - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
TTRX - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
TTRX - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
TTRX - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

TTRX - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
TTRX Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
TTRX Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
TTRX Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
TTRX Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

TTRX - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
TTRX Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
TTRX Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
TTRX Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
TTRX Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
TTRX Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TTRX - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
TTRX Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for TTRX

Based on past 1-year performance, here are TTRX growth metrics:

Share price CAGR of +90.14%
Dividend CAGR of +0%

Using TTRX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

TTRX (DRIP)TTRX - No DRIP
Current Price$13.31$13.31
Start Shares751.31751.31
Start Value$10,000$10,000
  
After 10 years:
Final Share Count751.31751.31
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$13.31$13.31
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - TTRX

NOTE: Above numbers are our estimate based on TTRX's Dividend and Price CAGR over past 1 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Turn Therapeutics Inc. (TTRX) had its IPO on 2025-10-08, and is traded on NASDAQ stock exchange.

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

TTRX website: https://www.turntherapeutics.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — TTRX

Value from:
Pay up to today
—
vs current price $13.31
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →